<ArticleSet>
<Article>
<Journal>
<PublisherName></PublisherName>
<JournalTitle>International Journal of Preventive Medicine</JournalTitle>
<Issn>2008-7802</Issn>
<Volume>3</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2012</Year>
<Month>04</Month>
<Day>15</Day>
</PubDate>
</Journal>
<ArticleTitle>A Case of Congenital Lipoid Adrenal Hyperplasia</ArticleTitle>
<FirstPage>677</FirstPage>
<LastPage>677</LastPage>
<Language>EN</Language>
<AuthorList>
<Author>
<FirstName>Mahin</FirstName>
<LastName>Hashemipour</LastName>
<Affiliation>. hashemipour@med.mui.ac.ir</Affiliation>
</Author>
<Author>
<FirstName>Mahmoud</FirstName>
<LastName>Ghasemi</LastName>
</Author>
<Author>
<FirstName>Silva</FirstName>
<LastName>Hovsepian</LastName>
</Author>
</AuthorList>
<History>
<PubDate>
<Year>2012</Year>
<Month>04</Month>
<Day>14</Day>
</PubDate>
<PubDate>
<Year>2012</Year>
<Month>04</Month>
<Day>14</Day>
</PubDate>
</History>
<Abstract>Lipoid congenital adrenal hyperplasia (lipoid CAH), a rare disorder of steroid biosynthesis, is the most severe form of CAH. In this disorder the synthesis of glucocorticoids, mineralocorticoids and sex steroids is impaired which result in adrenal failure, severe salt wasting crisis and hyperpigmentation in phenotypical female infants irrespective of genetic sex. In this report, we presented a 28‑day‑old phenotypic female infant, which referred with lethargy, failure to thrive and electrolyte abnormalities. Considering the clinical and biochemical findings, lipoid CAH was diagnosed and replacement therapy with standard doses of glucocorticoid and mineralocorticoid and sodium chloride was initiated. During follow‑up, she had good clinical condition, but at 6 years of age, she refers with hypertension and adrenal insufficiency because of arbitrary drug discontinuation by mother. In ultrasonography an abdominal mass (the testicles) was reported. Chromosome study showed 46XY pattern. Orchiectomy was performed. We recommended that in cases with clinical presentation of adrenal insufficiency if there is not the facility to determine the karyotype, repeated ultrasonography perform during follow‑up. In addition, investigating the genetic bases of the disorder would help us to determine the pathogenesis of lipoid CAH in our community. It would be helpful in prenatal diagnosis and treatment of the disorder to prevent its related comorbidities&nbsp;</Abstract>
</Article>
</ArticleSet>